Home/Filings/4/0000950170-25-018130
4//SEC Filing

Dworak Leiden 4

Accession 0000950170-25-018130

CIK 0001783328other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 5:54 PM ET

Size

5.4 KB

Accession

0000950170-25-018130

Insider Transaction Report

Form 4
Period: 2024-01-12
Dworak Leiden
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-12+46,87546,875 total
    Exercise: $6.00Exp: 2034-01-12Voting Common Stock (46,875 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 12, 2024, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.

Documents

1 file

Issuer

TScan Therapeutics, Inc.

CIK 0001783328

Entity typeother

Related Parties

1
  • filerCIK 0001986012

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 5:54 PM ET
Size
5.4 KB